Aligos Therapeutics Inc Earnings
The next earnings date for Aligos Therapeutics Inc has not yet been scheduled.
Analyst Estimates of Aligos Therapeutics Inc Earnings
| No results. | |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Aligos Therapeutics Inc Earnings: Historical
| 08/06/2026 | Before Market | $-0.14 | 90.07% |
| 05/08/2026 | --- | $-2.21 | 6.77% |
| 03/05/2026 | Before Market | $-1.91 | 23.29% |
| 11/06/2025 | Before Market | $-3.04 | -51.24% |
| 08/06/2025 | After Market | $-1.53 | 39.53% |
| 05/06/2025 | Before Market | $5.12 | 262.54% |
| 03/10/2025 | Before Market | $-13.10 | -256.95% |
| 11/06/2024 | After Market | $-3.07 | -132.58% |
| 08/06/2024 | After Market | $0.75 | 118.75% |
| 05/07/2024 | After Market | $-5.50 | -15.79% |
More About Aligos Therapeutics Inc
Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in liver and viral diseases. Its drug candidate, ALG-055009, a small molecule THR-ß agonist that is in the Phase 2a clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis and obesity. The company also develops pevifoscorvir sodium, a capsid assembly modulator, which is in Phase 2 B clinical trial; and ALG-097558, a small molecule ritonavir-free pan-coronavirus protease inhibitor which has completed a Phase 1 clinical trial for the treatment of coronavirus. The company has entered into license and research collaboration agreement with Emory University; and Katholieke Universiteit Leuven. Aligos Therapeutics, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.
“Aligos Therapeutics Inc Earnings” Can Refer to the Aligos Therapeutics Inc Earnings Date
Some people say “Aligos Therapeutics Inc earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Aligos Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Aligos Therapeutics Inc Stock on the Earnings Date
If you own Aligos Therapeutics Inc stock (ALGS) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Aligos Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Aligos Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More Aligos Therapeutics Inc Earnings
You can contact us any time if you would like to ask questions about Aligos Therapeutics Inc earnings or anything else related to the stock market.